Sioux Falls, SD, United States
Dr. Mitch Ibach is a residency trained optometrist at Vance Thompson Vision in Sioux Falls, SD. Dr. Ibach attended the Pacific University College of Optometry where he graduated summa cum laude. Mitch completed his residency training at Minnesota Eye Consultants with a concentration on cornea, refractive surgery, external disease and glaucoma. In September of 2014, he joined Vance Thompson Vision to focus on advanced anterior segment surgery care and pathology. Mitch is a fellow of the American Academy of Optometry, an Intrepid Eye Society member, a board member for the International Keratoconus Academy (IKA), a member with the American Optometric Association, Optometric Glaucoma Society (OGS), and the South Dakota Optometric Society. Dr. Ibach is the residency coordinator at Vance Thompson Vision, and is also an adjunct clinical faculty for the Illinois College of Optometry and the Northeastern State University Oklahoma, College of Optometry (NSUOCO).
112 - Corneal Ulcers from Z-A (Zoster to Acanthamoeba)
Friday, February 27, 2026
7:00 AM - 8:00 AM EDT
Disclosure(s): Balance Ophthalmics: Consulting Fees (), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (); C-Light technologies: Consulting Fees (); iCare: Consulting Fees (); Tarsus Pharma: Consulting Fees ()
114 - Next Gen SLT: What, When, Where
Friday, February 27, 2026
12:00 PM - 1:00 PM EDT
Disclosure(s): Balance Ophthalmics: Consulting Fees (), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (); C-Light technologies: Consulting Fees (); iCare: Consulting Fees (); Tarsus Pharma: Consulting Fees ()
125 - Sight Restored, Life Transformed: The Power of Modern IOLs
Friday, February 27, 2026
5:00 PM - 6:00 PM EDT
Disclosure(s): Balance Ophthalmics: Consulting Fees (), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (); C-Light technologies: Consulting Fees (); iCare: Consulting Fees (); Tarsus Pharma: Consulting Fees ()
Friday, February 27, 2026
6:00 PM - 7:00 PM EDT
Disclosure(s): Balance Ophthalmics: Consulting Fees (), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (); C-Light technologies: Consulting Fees (); iCare: Consulting Fees (); Tarsus Pharma: Consulting Fees ()
Saturday, February 28, 2026
7:00 AM - 8:00 AM EDT
Disclosure(s): Balance Ophthalmics: Consulting Fees (), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (); C-Light technologies: Consulting Fees (); iCare: Consulting Fees (); Tarsus Pharma: Consulting Fees ()